ZA884056B - Methods and compositions for the treatment of psoriasis - Google Patents

Methods and compositions for the treatment of psoriasis

Info

Publication number
ZA884056B
ZA884056B ZA884056A ZA884056A ZA884056B ZA 884056 B ZA884056 B ZA 884056B ZA 884056 A ZA884056 A ZA 884056A ZA 884056 A ZA884056 A ZA 884056A ZA 884056 B ZA884056 B ZA 884056B
Authority
ZA
South Africa
Prior art keywords
azidothymidine
compositions
psoriasis
treatment
methods
Prior art date
Application number
ZA884056A
Other languages
English (en)
Inventor
Madeleine Duvic
Duvic Madeleine
Gary W Brewton
W Brewton Gary
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas filed Critical Univ Texas
Publication of ZA884056B publication Critical patent/ZA884056B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A61K35/04—Tars; Bitumens; Mineral oils; Ammonium bituminosulfonate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
ZA884056A 1987-06-09 1988-06-07 Methods and compositions for the treatment of psoriasis ZA884056B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/059,907 US4804651A (en) 1987-06-09 1987-06-09 Methods and compositions for the treatment of psoriasis

Publications (1)

Publication Number Publication Date
ZA884056B true ZA884056B (en) 1989-06-28

Family

ID=22026060

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA884056A ZA884056B (en) 1987-06-09 1988-06-07 Methods and compositions for the treatment of psoriasis

Country Status (15)

Country Link
US (1) US4804651A (xx)
EP (1) EP0301206B1 (xx)
JP (1) JP2510675B2 (xx)
KR (1) KR950014447B1 (xx)
AT (1) ATE71301T1 (xx)
AU (1) AU606423B2 (xx)
DE (1) DE3867560D1 (xx)
DK (1) DK310188A (xx)
ES (1) ES2038716T3 (xx)
GR (1) GR3003785T3 (xx)
HU (1) HU200693B (xx)
IE (1) IE61091B1 (xx)
MY (1) MY103734A (xx)
PH (1) PH26517A (xx)
ZA (1) ZA884056B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5527779A (en) * 1988-03-23 1996-06-18 Top Gold Pty Limited Topically applied gold organic complex
AU620107B2 (en) * 1988-05-27 1992-02-13 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Compositions having use as treatment of psoriasis and neuropsychiatric deficits
US5098899A (en) * 1989-03-06 1992-03-24 Trustees Of Boston University Method for therapeutically treating psoriatic arthritis using vitamin D analogues and metabolites
JP2831030B2 (ja) * 1989-05-12 1998-12-02 学校法人城西大学 ３’‐アジド‐３’デオキシチミジンを有効成分とする経皮投与製剤用組成物
US5021422A (en) * 1989-06-08 1991-06-04 Senetek Plc Method and composition for treating hyperproliferative skin diseases using 6-aminopurine cytokinins
US5162361A (en) * 1990-04-10 1992-11-10 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Method of treating diseases associated with elevated levels of interleukin 1
JPH07500114A (ja) * 1991-12-13 1995-01-05 ジー．ディー．サール　アンド　カンパニー 経皮吸収性アジドチミジン
US5654286A (en) * 1993-05-12 1997-08-05 Hostetler; Karl Y. Nucleotides for topical treatment of psoriasis, and methods for using same
US5973010A (en) * 1998-05-15 1999-10-26 Crawford; Robert L. Composition for healing skin wounds
GR1003491B (el) * 1999-12-21 2000-11-30 Μεθοδος παρασκευης φαρμακοτεχνικου σκευασματος, αλοιφης η κρεμασκαι χρηση του στην αντιμετωπιση και θεραπεια της ψωριασεως και του εκζεματος
JP2009528382A (ja) * 2006-03-01 2009-08-06 トリストラータ・インコーポレイテッド タール応答性皮膚疾患の局所治療のための組成物及び方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK166805B1 (da) * 1985-03-16 1993-07-19 Wellcome Found Threo-isomeren af 3'-azido-3'-deoxythymidin til anvendelse ved behandling af eller profylakse for humane retrovirusinfektioner, anvendelse af forbindelsen til fremstilling af et laegemiddel med naevnte indikation og farmaceutisk praeparat indeholdende forbindelsen
IL85738A0 (en) * 1987-03-16 1988-08-31 Wellcome Found Nucleoside derivatives,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
ATE71301T1 (de) 1992-01-15
AU1751088A (en) 1988-12-15
ES2038716T3 (es) 1995-04-01
HUT47853A (en) 1989-04-28
DK310188D0 (da) 1988-06-08
AU606423B2 (en) 1991-02-07
KR890000093A (ko) 1989-03-11
HU200693B (en) 1990-08-28
EP0301206A2 (en) 1989-02-01
MY103734A (en) 1993-09-30
DE3867560D1 (de) 1992-02-20
EP0301206A3 (en) 1989-09-06
US4804651A (en) 1989-02-14
GR3003785T3 (xx) 1993-03-16
DK310188A (da) 1988-12-12
PH26517A (en) 1992-08-07
IE881708L (en) 1988-12-09
IE61091B1 (en) 1994-09-21
JPS6470417A (en) 1989-03-15
EP0301206B1 (en) 1992-01-08
JP2510675B2 (ja) 1996-06-26
KR950014447B1 (ko) 1995-11-28

Similar Documents

Publication Publication Date Title
US4654373A (en) Pharmaceutical formulations containing coenzyme Q10 suitable for topic administration
US5098899A (en) Method for therapeutically treating psoriatic arthritis using vitamin D analogues and metabolites
US5478814A (en) Hemorrhoidal, other compositions and methods of treatment
US4743597A (en) Composition comprising an oxygenated cholesterol and use thereof for topical treatment of diseases
US5654312A (en) Treatment of inflammatory and/or autoimmune dermatoses with thalidomide alone or in combination with other agents
US4393066A (en) Method for treatment of herpetic lesions
EP0391905A1 (en) HEMORRHOID COMPOSITION AND OTHER COMPOSITIONS AND TREATMENT METHODS.
GR3003785T3 (xx)
CA2120367A1 (en) Compositions and use of pharmaceutical compositions in the treatment of symptoms of disorders related to chronic inflammatory diseases and etiologically related symptomology
AU2004294691A1 (en) Compositions for the treatment of atopic dermatitis, skin allergic conditions and acne
Hay et al. Short course ketoconazole therapy in pityriasis versicolor
ES2147788T3 (es) 3,4-diarilcromanos para el tratamiento de la dermatitis.
Collier et al. Topical 5‐aminosalicylic acid: a treatment for aphthous ulcers
WO1999026613A1 (en) Aminoguanidine compositions for treating skin proliferative diseases
Lassus Colloidal silicic acid for the treatment of psoriatic skin lesions, arthropathy and onychopathy. A pilot study
GB9205670D0 (en) New derivatives of physostigmine,their use and pharmaceutical formulations containing them
IE853206L (en) Use of aminosulfonic acids in treatment of inflammatory¹conditions
AU1400895A (en) 2,3-diaryl-1-benzopyrans for treating dermatitis
CA2330659A1 (en) Using ngali nut oil to treat/relieve manifestations of arthritis and other similar conditions
US4751236A (en) Method for treating genital herpes
Vena et al. Topical 5-fluorouracil in the treatment of discoid lupus erythematosus. Preliminary study over two years
Thompson Cream may reduce eczema relapse
CA2379435A1 (en) Topical azathioprine for the treatment of oral autoimmune diseases